Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Chemours Company Sued for Securities Law Violations- Investors Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC

CC

NEW YORK, NY / ACCESSWIRE / April 9, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=74983&wire=1

or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

THE LAWSUIT: A class action securities lawsuit was filed against The Chemours Company that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February 10, 2023 and February 28, 2024.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) certain of the Company's senior executive officers manipulated Free Cash Flow targets as a means to maximize additional cash and stock incentive compensation applicable to executive officers pursuant to the Company's annual incentive plans and long-term incentive plans; (2) the Company's accounting practices and procedures, including its internal control over financial reporting, were deficient; and (3) as a result, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

WHAT'S NEXT? If you suffered a loss in The Chemours Company stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=74983&wire=1 to learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

SOURCE: Levi & Korsinsky, LLP



View the original press release on accesswire.com

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today